Skip to content
Identifying the causes of peripheral neuropathy in cancer patients can be difficult. There are many common causes of peripheral neuropathy in cancer patients. Neuropathic pain is defined as pain caused by a lesion or disease of the somatosensory nervous system. Peripheral neuropathies arise from disorders associated specifically within the peripheral nervous system. Symptoms of peripheral […]
May 5th thru the 12th is National Neuropathy Awareness Week. Neuropathy is a chronic condition that affects millions of people in America. While there is no cure for neuropathy, there are ways to manage the pain associated with it. Many groups including the Foundation for Peripheral Neuropathy and the American Health Council help patients dealing
Recent studies have reported that patients with Type 2 diabetes and diabetic peripheral neuropathy showed lower Vitamin D levels than patients without T2 diabetes or peripheral neuropathy. Some studies also found including a vitamin D supplementation could help improve painful neuropathic symptoms, which suggests vitamin D could have a role in diabetic peripheral neuropathy. Low
Women who take multivitamin supplements before their breast cancer diagnosis and during chemotherapy appear to be less likely to develop the debilitating, often long-lasting symptoms of chemotherapy-induced peripheral neuropathy (CIPN), according to a new study. In a large study of breast cancer patients undergoing paclitaxel chemotherapy, those who used multivitamins were about 40% less
Long-term uncontrolled glycemic levels primary cause of complication in diabetes, such as diabetic peripheral neuropathy. There is a gradual increase in incidence of type 1 diabetes (T1D) and type 2 diabetes (T2D) among the U.S. youth population. Studies show that if this continues, diabetes prevalence among the youth population will triple within three decades. One
Nicotinamide riboside (NR), a type of vitamin B3, may prevent chemotherapy-induced peripheral neuropathy (CIPN), a recent study in animals has shown. Although chemotherapy increases survival rates, it can have serious side effects, including peripheral neuropathy, that affect quality of life.1 “Our findings support the idea that NR could potentially be used to prevent or mitigate
Diabetic peripheral neuropathy affects approximately 60-70% of diabetic patients and a total of 347 million people worldwide.1 This complication is not only associated with painful symptoms, but can also lead to significant consequences such as paresthesia, loss of sensation, ulcers, osteomyelitis, gangrene, foot deformities, and amputation. Common symptoms of diabetic peripheral neuropathy are listed in
Dr. Brian M. Ilfeld, MD, MS, feels this strongly about the potential for ultrasound-guided percutaneous peripheral nerve stimulation. It’s a technology that he says has the potential to forever change the way anesthesiologists treat acute postoperative pain. He discussed the results of a prospective feasibility study. As well as the potential for the technology’s future—at
Transdermal buprenorphine may be an effective therapy for diabetic peripheral neuropathic pain (DPNP). However the treatment was associated with a high rate of adverse events, mostly nausea and/or vomiting. The findings come from a newly published multi-center, randomized, double-blind, placebo-controlled, parallel-group trial. Ninety-three patients with type 1 or 2 diabetes were enrolled and received either
Neurology researchers link mutations in myelin protein to Charcot-Marie-Tooth Disease, an inherited neuropathy. PHILADELPHIA – Charcot-Marie-Tooth Disease (CMT) is in the family of inherited neuropathy, of the peripheral nervous system, affecting approximately one in 2,500 Americans. Its most common iteration, CMT1, comes in many forms, most of which have to date been linked to a small
